Last update 08 May 2025

[18F] Dihydro-testosterone

Overview

Basic Info

Drug Type
Diagnostic radiopharmaceuticals, Radionuclide Drug Conjugates (RDC)
Synonyms
18F-FDHT
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsUrogenital DiseasesSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Advanced breast cancerLocalized Prostate CarcinomaMetastatic breast cancer
Originator Organization
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center
Active Organization-
Inactive Organization
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center
License Organization-
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

2
Clinical Trials associated with [18F] Dihydro-testosterone
NCT06145399
/ WithdrawnEarly Phase 1IIT
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone PET Imaging In Patients Advanced Breast Cancer
NCT02297386
/ CompletedPhase 1IIT
Phase I Trial Of [18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer
100 Clinical Results associated with [18F] Dihydro-testosterone
Login to view more data
100 Translational Medicine associated with [18F] Dihydro-testosterone
Login to view more data
100 Patents (Medical) associated with [18F] Dihydro-testosterone
Login to view more data
100 Deals associated with [18F] Dihydro-testosterone
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced breast cancerPhase 1-
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center
24 Oct 2023
Metastatic breast cancerPhase 1-
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center
24 Oct 2023
Localized Prostate CarcinomaPhase 1
United States
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center
01 Nov 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free